Cargando…

Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system

Bispecific antibodies have emerged in recent years as a promising field of research for therapies in oncology, inflammable diseases, and infectious diseases. Their capability of dual target recognition allows for novel therapeutic hypothesis to be tested, where traditional mono-specific antibodies w...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yiren, Lee, John, Tran, Cuong, Heibeck, Tyler H, Wang, Willie D, Yang, Junhao, Stafford, Ryan L, Steiner, Alexander R, Sato, Aaron K, Hallam, Trevor J, Yin, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623329/
https://www.ncbi.nlm.nih.gov/pubmed/25427258
http://dx.doi.org/10.4161/19420862.2015.989013
_version_ 1782397668920655872
author Xu, Yiren
Lee, John
Tran, Cuong
Heibeck, Tyler H
Wang, Willie D
Yang, Junhao
Stafford, Ryan L
Steiner, Alexander R
Sato, Aaron K
Hallam, Trevor J
Yin, Gang
author_facet Xu, Yiren
Lee, John
Tran, Cuong
Heibeck, Tyler H
Wang, Willie D
Yang, Junhao
Stafford, Ryan L
Steiner, Alexander R
Sato, Aaron K
Hallam, Trevor J
Yin, Gang
author_sort Xu, Yiren
collection PubMed
description Bispecific antibodies have emerged in recent years as a promising field of research for therapies in oncology, inflammable diseases, and infectious diseases. Their capability of dual target recognition allows for novel therapeutic hypothesis to be tested, where traditional mono-specific antibodies would lack the needed mode of target engagement. Among extremely diverse architectures of bispecific antibodies, knobs-into-holes (KIHs) technology, which involves engineering C(H)3 domains to create either a “knob” or a “hole” in each heavy chain to promote heterodimerization, has been widely applied. Here, we describe the use of a cell-free expression system (Xpress CF) to produce KIH bispecific antibodies in multiple scaffolds, including 2-armed heterodimeric scFv-KIH and one-armed asymmetric BiTE-KIH with tandem scFv. Efficient KIH production can be achieved by manipulating the plasmid ratio between knob and hole, and further improved by addition of prefabricated knob or hole. These studies demonstrate the versatility of Xpress CF in KIH production and provide valuable insights into KIH construct design for better assembly and expression titer.
format Online
Article
Text
id pubmed-4623329
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-46233292015-11-26 Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system Xu, Yiren Lee, John Tran, Cuong Heibeck, Tyler H Wang, Willie D Yang, Junhao Stafford, Ryan L Steiner, Alexander R Sato, Aaron K Hallam, Trevor J Yin, Gang MAbs Reports Bispecific antibodies have emerged in recent years as a promising field of research for therapies in oncology, inflammable diseases, and infectious diseases. Their capability of dual target recognition allows for novel therapeutic hypothesis to be tested, where traditional mono-specific antibodies would lack the needed mode of target engagement. Among extremely diverse architectures of bispecific antibodies, knobs-into-holes (KIHs) technology, which involves engineering C(H)3 domains to create either a “knob” or a “hole” in each heavy chain to promote heterodimerization, has been widely applied. Here, we describe the use of a cell-free expression system (Xpress CF) to produce KIH bispecific antibodies in multiple scaffolds, including 2-armed heterodimeric scFv-KIH and one-armed asymmetric BiTE-KIH with tandem scFv. Efficient KIH production can be achieved by manipulating the plasmid ratio between knob and hole, and further improved by addition of prefabricated knob or hole. These studies demonstrate the versatility of Xpress CF in KIH production and provide valuable insights into KIH construct design for better assembly and expression titer. Taylor & Francis 2014-11-26 /pmc/articles/PMC4623329/ /pubmed/25427258 http://dx.doi.org/10.4161/19420862.2015.989013 Text en © 2015 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Reports
Xu, Yiren
Lee, John
Tran, Cuong
Heibeck, Tyler H
Wang, Willie D
Yang, Junhao
Stafford, Ryan L
Steiner, Alexander R
Sato, Aaron K
Hallam, Trevor J
Yin, Gang
Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system
title Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system
title_full Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system
title_fullStr Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system
title_full_unstemmed Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system
title_short Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system
title_sort production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system
topic Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623329/
https://www.ncbi.nlm.nih.gov/pubmed/25427258
http://dx.doi.org/10.4161/19420862.2015.989013
work_keys_str_mv AT xuyiren productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem
AT leejohn productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem
AT trancuong productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem
AT heibecktylerh productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem
AT wangwillied productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem
AT yangjunhao productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem
AT staffordryanl productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem
AT steineralexanderr productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem
AT satoaaronk productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem
AT hallamtrevorj productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem
AT yingang productionofbispecificantibodiesinknobsintoholesusingacellfreeexpressionsystem